The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Young Investigator Awards
The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Young Investigator Awards. We especially encourage young investigators working on prostate cancer health disparities to apply.
PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used innovatively and flexibly to advance the career and research efforts of the awardee. This for example, includes funding “protected time” or direct costs for laboratory science. This award does not support indirect costs such as institutional overhead. Every PCF Young Investigator is required to be under the direct supervision of 1-3 mentors. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Forum, typically held in October, throughout the duration of their award.
Research proposals addressing disparities in care experienced by patients with prostate cancer may focus on implementation research in various populations (e.g. urban vs rural, racial, geographic or financial) or in drivers of care and outcome disparities that could potentially be addressed through changes in policy, advocacy or education. Applicants are encouraged to solicit and integrate advice from patients, patient support groups or advocates. Letters of support demonstrating such relationships are recommended.
The deadline for emailing your LOI form to LettersOfIntent@pcf.org is Friday, February 10, 2023, 3:00pm, Eastern Standard Time (EST).
PCF seeks applications from the global biomedical research community. Applicants traditionally under-represented in science and medicine are highly encouraged. We seek applications from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of prostate cancer. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. However, successful applicants should be working in an academic research environment capable of supporting transformational prostate cancer research. Access to and real-time interaction with a clinical environment and translational prostate cancer physician-scientists is highly desired.
• Applicant must be within six-years following completion of a professional degree (MD, DO, PhD, MD-PhD, DSc, ScD, DDM, DDS, DMD, MBBS, or equivalent) or subsequent mentored academic or clinical training program.
• Applicant must hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor or equivalent.
• Applicant must be under the direct supervision of a mentor(s). At least one mentor at the applicant’s institution is required.
• The Applicant should not have been granted commitments for more than $300,000 in direct research funding from all sources including institutional funds at the time of this application. VA Career Development Awardees are excluded from this limit.
• VA Career Development Awardees are eligible to apply for this award provided they have completed at least 3 years of the Career Development Award by the time of application submission to PCF